BMGL
Basel Medical Group Ltd
$0.5900
+2.08%
$11.1M
No data for this timeframe.
Vol
Market Cap$11.1M
Cap SizeNano Cap
SEC Reports3
Press Releases1
Exchange Nasdaq·Sector Services-Offices & Clinics of Doctors of Medicine·Inc. D8·CIK 0002004489·Prev Close $0.5780
Recent Activity
Jun 10, 2026
SEC
Analysis based on filing metadata only — document content was unavailable. Basel Medical Group Ltd filed a Form 6-K with
6-K — Impact 3/10
Jun 10, 2026
other
BMGL to Effect Reverse Share Split on June 22, 2026
<p align="justify">SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: B
Jun 5, 2026
SEC
Basel Medical Group Ltd announced the appointment of Mr. Neo Chun How Alton as interim CFO, effective June 2, 2026, repl
6-K — Impact 3/10
Mar 30, 2026
SEC
Basel Medical Group Ltd appointed Mr. Tan Boon Chye (Darren), its Chief Commercial Officer, to the board of directors, r
6-K — Impact 3/10
Mar 24, 2026
Press
Basel Medical Group Ltd announced it has resolved its Nasdaq filing deficiency after submitting its amended 2025 annual
Impact 3/10
Latest Reports
NEUTRAL
6-K
3/10
Analysis based on filing metadata only — document content was unavailable. Basel Medical Group Ltd filed a Form 6-K with
Jun 10, 2026
NEUTRAL
6-K
3/10
Basel Medical Group Ltd announced the appointment of Mr. Neo Chun How Alton as interim CFO, effective June 2, 2026, repl
Jun 5, 2026
NEUTRAL
Press
3/10
Basel Medical Group Ltd announced it has resolved its Nasdaq filing deficiency after submitting its amended 2025 annual
Mar 24, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.0/10.
NEUTRAL
6-K
3/10
Analysis based on filing metadata only — document content was unavailable. Basel Medical Group Ltd f
Jun 10, 2026
NEUTRAL
6-K
3/10
Basel Medical Group Ltd announced the appointment of Mr. Neo Chun How Alton as interim CFO, effectiv
Jun 5, 2026
NEUTRAL
6-K
3/10
Basel Medical Group Ltd appointed Mr. Tan Boon Chye (Darren), its Chief Commercial Officer, to the b
Mar 30, 2026
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 10, 2026
other
BMGL to Effect Reverse Share Split on June 22, 2026
<p align="justify">SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), a medical clinic operator in
Jun 3, 2026
short_volume
Short Volume: BMGL — 56.0% short (1.2M / 2.1M)
Short: 1,189,960 | Exempt: 200,128 | TRF Vol: 2,123,607 | Short Ratio: 56.0% | Off-exchange volume (dark pool + OTC)
Mar 24, 2026
earnings
Compliance With Nasdaq Periodic Filing Requirement
<p align="justify"><b>Singapore, March 24, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd</b> (Nasdaq: BMGL) (the “Company”) today announced that